Search publication

Via Vittorio Alfieri,17
Torino (Italy)

FOLLOW US

CONTACTS

+39011.76.51.239
info@adreshe.com

A 1-year per-patient cost of therapy administration analysis of mosunetuzumab and tisagenlecleucel in relapsed or refractory follicular lymphoma patients receiving  two or more lines of systemic therapy

Bellone M, Sabinot A, D’Arpino A, et al. Glob Reg Health Technol Assess 2024; 11: 239-47